SARS-CoV-2 Rebound Rate Similar With, Without Oral Antivirals

FRIDAY, Dec. 22, 2023 -- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rebound occurs at a similar rate for those receiving and not receiving oral antiviral treatment and for those receiving nirmatrelvir/ritonavir or placebo,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news